Fritz, G
Targeting the mevalonate pathway for improved anticancer therapy.Curr Cancer Drug Targets. Bd. 9. H. 5. 2009 S. 626-38
Naumann, SC; Roos, WP; Jost, E et al.
Temozolomide cells: response related to MGMT, MMR, DSBs, and p53Br J Cancer. Bd. 100. H. 2. 2009 S. 322-33
Roos, WP; Tsaalbi-Shtylik, A; Tsaryk, R et al.
The translesion polymerase Rev3L in the tolerance of alkylating anticancer drugsMol Pharmacol. Bd. 76. H. 4. 2009 S. 927-34
Brozovic, A; Majhen, D; Roje, V et al.
alpha(v)beta(3) Integrin-mediated drug resistance in human laryngeal carcinoma cells is caused by glutathione-dependent elimination of drug-induced reactive oxidative speciesMol Pharmacol. Bd. 74. H. 1. 2008 S. 298-306
Goldstein, M; Roos, WP; Kaina, B
Apoptotic death induced by the cyclophosphamide analogue mafosfamide in human lymphoblastoid cells: contribution of DNA replication, transcription inhibition and Chk/p53 signaling.Toxicol Appl Pharmacol. Bd. 229. H. 1. 2008 S. 20-32
Li, PC; Lam, E; Roos, WP et al.
Artesunate derived from traditional Chinese medicine induces DNA damage and repairCancer Res. Bd. 68. H. 11. 2008 S. 4347-51
Bockamp, Ernesto; Sprengel, Rolf; Eshkind, Leonid et al.
Conditional transgenic mouse models: from the basics to genome-wide sets of knockouts and current studies of tissue regenerationREGENERATIVE MEDICINE. Bd. 3. H. 2. 2008 S. 217-235
Koberle, B; Roginskaya, V; Zima, KS et al.
Elevation of XPA protein level in testis tumor cells without increasing resistance to cisplatin or UV radiation.Mol Carcinog. Bd. 47. H. 8. 2008 S. 580-6
Wilson, Anne; Laurenti, Elisa; Oser, Gabriela et al.
Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and RepairCELL. Bd. 135. H. 6. 2008 S. 1118-1129
Sprengel, R; Eshkind, L; Hengstler, J et al.
Improved models for animal researchHumana Press 2008 17 S.